1243245-77-3Relevant articles and documents
Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors
Cheng, Dai,Liu, Jun,Han, Dong,Zhang, Guobao,Gao, Wenqi,Hsieh, Mindy H.,Ng, Nicholas,Kasibhatla, Shailaja,Tompkins, Celin,Li, Jie,Steffy, Auzon,Sun, Fangxian,Li, Chun,Seidel, H. Martin,Harris, Jennifer L.,Pan, Shifeng
supporting information, p. 676 - 680 (2016/07/26)
Blockade of aberrant Wnt signaling is an attractive therapeutic approach in multiple cancers. We developed and performed a cellular high-throughput screen for inhibitors of Wnt secretion and pathway activation. A lead structure (GNF-1331) was identified from the screen. Further studies identified the molecular target of GNF-1331 as Porcupine, a membrane bound O-acyl transferase. Structure-activity relationship studies led to the discovery of a novel series of potent and selective Porcupine inhibitors. Compound 19, GNF-6231, demonstrated excellent pathway inhibition and induced robust antitumor efficacy in a mouse MMTV-WNT1 xenograft tumor model.
